Idarucizumab brand name

FDA Approved: Yes (First approved Octo) ; Brand name: Praxbind ; Generic name: idarucizumab ; Dosage form: Injection ; Company:

Idarucizumab, sold under the brand name Praxbind, is a monoclonal antibody used as a reversal agent for dabigatran. Idarucizumab was developed by Boehringer Ingelheim - Wikipedia.

brand name Praxbind, according to the company. Labeling for idarucizumab states that it is a recombinant humanized monoclonal antibody that binds to

Trade Brand of Technology: A trade name for idarucizumab has not yet been finalized. 4. Brief Description of Service, Device or Drug:.

Pradaxa. The approval of the antidote, known by the brand name Praxbind and the generic name idarucizumab, makes Pradaxa the first in its

Idarucizumab, sold under the brand name Praxbind, is a monoclonal antibody designed for the reversal of anticoagulant effects ofdabigatran.

Generic name: idarucizumab systemic. Brand names: Praxbind. Reviewed by Medicine.com on Febru. Consumer; Health Professional. On this page.

Idarucizumab, sold under the brand name Praxbind, is a monoclonal antibody used as a reversal agent for dabigatran. Idarucizumab

Idarucizumab, sold under the brand name Praxbind, is a monoclonal antibody used as a reversal agent for dabigatran. [4] Idarucizumab was developed by Boehringer Ingelheim. One study sponsored by the manufacturer found that idarucizumab effectively reversed anticoagulation caused by dabigatran within minutes. [6]